Sotac Pharmaceuticals Limited (NSE:SOTAC)
India · Delayed Price · Currency is INR 111.00
0.00 (0.00%)
May 29, 2026, 2:33 PM IST
Sotac Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 57.67 | 80.27 | 42.81 | 28.79 | 28.79 |
Depreciation & Amortization | 54.06 | 38.3 | 30.95 | 22.76 | 11.26 |
Other Amortization | - | 0.05 | 0.05 | 0.02 | 0.01 |
Loss (Gain) From Sale of Assets | -0.7 | - | - | - | - |
Loss (Gain) From Sale of Investments | - | - | -1.29 | - | 18.36 |
Other Operating Activities | 48.95 | 47.15 | -26.22 | 14.13 | 4.24 |
Change in Accounts Receivable | 11.62 | -78.25 | -115.47 | 38.11 | -62.71 |
Change in Inventory | -68.16 | -22.51 | -43.68 | -44.65 | -15.96 |
Change in Accounts Payable | 82.47 | -99.49 | 35 | -47.85 | 94.27 |
Change in Other Net Operating Assets | -17.23 | -8.84 | -82.93 | 70.12 | -14.76 |
Operating Cash Flow | 168.67 | -43.31 | -160.76 | 81.43 | 63.51 |
Operating Cash Flow Growth | - | - | - | 28.22% | - |
Capital Expenditures | -78.94 | -170.16 | -177.89 | -90 | -35.04 |
Sale of Property, Plant & Equipment | 0.8 | 0.03 | 0.09 | 13.14 | - |
Investment in Securities | 8.66 | -16.86 | -20.96 | -40.02 | -0.59 |
Other Investing Activities | 0.51 | 50.83 | 1.8 | 0.46 | 0.48 |
Investing Cash Flow | -68.98 | -136.16 | -196.79 | -116.74 | -35.15 |
Short-Term Debt Issued | - | 167.78 | - | 31.07 | 24.56 |
Long-Term Debt Issued | 34.57 | 20.63 | 43.62 | 6.54 | - |
Total Debt Issued | 34.57 | 188.41 | 43.62 | 37.61 | 24.56 |
Short-Term Debt Repaid | -22.96 | - | -15.42 | - | - |
Long-Term Debt Repaid | -72.64 | - | - | - | -17.48 |
Total Debt Repaid | -95.6 | - | -15.42 | - | -17.48 |
Net Debt Issued (Repaid) | -61.03 | 188.41 | 28.2 | 37.61 | 7.08 |
Issuance of Common Stock | - | - | 333 | 112.66 | - |
Common Dividends Paid | -1.11 | - | - | - | -4.6 |
Other Financing Activities | -41.42 | -27.48 | -66.29 | -18.9 | -30.78 |
Financing Cash Flow | -103.55 | 160.93 | 294.91 | 131.36 | -28.3 |
Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - |
Net Cash Flow | -3.86 | -18.54 | -62.64 | 96.05 | 0.05 |
Free Cash Flow | 89.73 | -213.47 | -338.65 | -8.57 | 28.46 |
Free Cash Flow Margin | 8.83% | -21.29% | -32.57% | -1.11% | 3.89% |
Free Cash Flow Per Share | 8.12 | -19.32 | -30.85 | -1.06 | 3.54 |
Cash Interest Paid | 41.28 | 22.32 | 15.23 | 18.64 | 5.32 |
Cash Income Tax Paid | 20.8 | 8.05 | 16.91 | 16.84 | 18.59 |
Levered Free Cash Flow | 33.58 | -263.43 | -323.71 | -54.33 | -10.71 |
Unlevered Free Cash Flow | 59.38 | -249.47 | -314.02 | -42.44 | -7.57 |
Change in Working Capital | 8.69 | -209.08 | -207.07 | 15.73 | 0.85 |